Corcept Therapeutics | CORT - Stock


Corcept Therapeutics reported $12.35M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Ardelyx USD 129.36M 107.08M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Corcept Therapeutics USD 12.35M 73K Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
J&J USD 14.15B 734M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 157.68M 9.52M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025